Clinical Trial Update: Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of vaginal testosterone cream for atrophic vaginitis in women treated with aromatase inhibitors for breast cancer has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms
• Dyspareunia
• Vaginitis

Drugs mentioned

• Vaginal testosterone cream (testosterone)

Snippet

Sponsor: University of Vermont | Conditions: Vaginitis, Dyspareunia | Phase 1, Phase 2 | Status: SUSPENDED